FDA approves Lexapro for generalized anxiety disorder in children

Lexapro (escitalopram) is now FDA-approved for the treatment of generalized anxiety disorder in pediatric patients 7 years of age and older. Previously, the treatment had only been approved for adults. Prescribing information for Lexapro contains a Boxed Warning about increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants.